News

Avacta claimed that Optim fills a significant gap in the market by providing detailed analysis using only very small sample volumes, and also enables drug developers to gain

Revenue in markets outside the US increased by 7%, including a 14% increase in Emerging Markets. Revenue in Western Europe was up 3%. Revenue in Established Rest of

Human-cl rhFVIII is a recombinant factor VIII (rFVIII) concentrate developed by Octapharma for the control and prevention of bleeding episodes and for surgical prophylaxis in patients with hemophilia

Methotrexate is an antimetabolite used in the treatment of neoplastic diseases, severe psoriasis, and rheumatoid arthritis, including polyarticular juvenile rheumatoid arthritis. Sandoz is initiating this voluntary recall of

The fluoroquinolone intravenous anti-bacterial agent comes in 500mg/100ml IV bags and 500mg/20ml injections (Cravit IV). Cravit IV, administered once daily, is classified as a respiratory quinolone suited to

SOHM said that the pharmaceutical order is expected to drive revenue in 2010 and 2011 as future orders are delivered. SOHM Inc Corporate Strategy vice president Shailesh Shah

The current approval is the second approval of this new oral anticoagulant following the recent marketing authorisation by the US Food and Drug Administration (FDA). The approval is

R-Bambuterol Hydrochloride is categorized as a Class I new drug. In preclinical studies, R-Bambuterol Hydrochloride demonstrated a promising efficacy and safety profile. Obtaining permission from the SFDA Ethics

Novartis plans to expand its current Massachusetts Avenue campus, adjacent to MIT, by more than 400,000 sft, including laboratory, office and retail space. Construction is expected to begin